Literature DB >> 7930638

Monoclonal antibody EG2 does not provide reliable immunohistochemical discrimination between resting and activated eosinophils.

F L Jahnsen1, P Brandtzaeg, T S Halstensen.   

Abstract

The monoclonal antibody (mAb) EG2 has been considered to identify activated eosinophils and several immunohistochemical reports of EG2+ eosinophils in various allergic and other inflammatory disorders have suggested an important pathogenic role for such cells. This study showed that cellular EG2 reactivity, both in peripheral blood and mucosal tissue preparations, depends mainly on the method of sample preparation. Nearly 100% of blood eosinophils from normal individuals were strongly EG2+ when prepared by formalin fixation, whereas only a fraction reacted in the unfixed (64%) or acetone-fixed (60%) state. A significantly increased (p < 0.03) number of EG2+ cells were likewise detected in cryo-sections of inflamed nasal mucosa after formalin fixation compared with acetone fixation. Moreover, virtually all eosinophils were EG2+ in cryo-sections of normal jejunal mucosa fixed in periodate-lysine-(0.5%) paraformaldehyde prior to freezing. Conversely, EG2 reacted only weakly, or failed to react, with many eosinophils in cryo-material not subjected to such pre-fixation, in contrast to adjacent non-eosinophilic cells which were brightly stained. Two-colour immunofluorescence consistently revealed overlapping labelling with EG2 and mAb EG1 or a polyclonal antibody to eosinophil cationic protein in sections of formalin-fixed, paraffin-embedded normal gastrointestinal mucosa. Our findings thus showed that EG2 does not provide reliable immunohistochemical discrimination between resting and activated eosinophils. When optimal pre-fixation of tissue specimens was omitted, EG2 reactivity appeared to be caused, at least in part, by leached antigen adsorbed to adjacent non-eosinophilic cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7930638     DOI: 10.1016/0022-1759(94)90328-x

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  5 in total

1.  Biomarkers of eosinophil involvement in allergic and eosinophilic diseases: review of phenotypic and serum markers including a novel assay to quantify levels of soluble Siglec-8.

Authors:  Ho Jeong Na; Robert G Hamilton; Amy D Klion; Bruce S Bochner
Journal:  J Immunol Methods       Date:  2012-06-06       Impact factor: 2.303

2.  The impact of eotaxin- and IL-5-induced adhesion and transmigration on eosinophil activity markers.

Authors:  E Fernvik; J Lundahl; G Halldén
Journal:  Inflammation       Date:  2000-02       Impact factor: 4.092

3.  Degranulation patterns of eosinophil granulocytes as determinants of eosinophil driven disease.

Authors:  J S Erjefält; L Greiff; M Andersson; E Adelroth; P K Jeffery; C G Persson
Journal:  Thorax       Date:  2001-05       Impact factor: 9.139

4.  Cell specific markers for eosinophils and neutrophils in sputum and bronchoalveolar lavage fluid of patients with respiratory conditions and healthy subjects.

Authors:  Tuula Metso; P Venge; T Haahtela; C G B Peterson; L Sevéus
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

Review 5.  Immunocompetent cells of the upper airway: functions in normal and diseased mucosa.

Authors:  P Brandtzaeg
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.